🏢 官网IRNVSTQwen · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 04:10:00(美东 09-08 16:10)·⟳ 抓取 04:10:46回填·⚡ 决策 09-09 04:51:21·49.0 天前
Envista（NVST.US）公告将出席 Baird 2026 全球医疗健康大会并于 9 月 15 日进行炉边对话，属例行投资者关系活动通知，无财务或经营增量信息
正文本身即为完整一手通稿，内容只是投资者会议日程与公司简介，不存在任何可以改变盈利预期、现金流、订单或估值的增量事实；Web、KB、行情、供应链或历史先例检索都不可能改变「不做」的结论，故按源级早停直接给出完整 AVOID，不消耗额外工具调用
📄 原文NVST↗ 原文
Envista Announces Participation in Baird 2026 Global Healthcare Conference
BREA, Calif. , Sept. 8, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced th…
不做 Envista Holdings（NVST.US）
公告仅为参加 Baird 2026 全球医疗健康大会(9 月 15 日 9:40–10:10 AM ET 炉边对话)的日程通知与公司背景模板，无指引、订单、业绩、并购或治理层面的任何增量事实，不存在事件驱动的方向与 edge；同时美股已收盘进入盘后，无当日可执行窗口。属典型 IR 噪音，不做多也不做空。若 9 月 15 日对话现场披露新的指引或业务更新，应作为独立新事件重新研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事实：Envista 于 2026-09-08 20:10 UTC 通过 PRNewswire/公司 IR 发布通稿，宣布 9 月 15 日在 Baird 全球医疗健康大会进行 30 分钟炉边对话，并提供直播与回放链接，其余为品牌与 IR 联系人模板文字。影响链：出席卖方主办会议属上市公司常规 IR 活动，不产生收入、订单、指引、资本配置或治理变化，对公司价值无因果传导；市场对此类日程公告通常无定价反应。价格/证据：一手通稿已完整给出全部信息，无需额外核实；美股此刻已收盘(16:50 ET 盘后)，即使存在微弱情绪影响也没有可执行窗口。结论：无增量事实、无可交易 edge、无标的映射，AVOID；若 9 月 15 日对话中出现实质性指引或业务更新，应作为新事件重新研判。
🔎 新鲜度:最早出现 2026-09-08 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:先例缺失未改变结论；本条判定完全基于正文无增量事实这一确定性依据，而非证据不足下的保守回避
方向:无先例输入：例行会议出席公告本身不构成可测事件类型，历史价格反应统计无决策意义
涨幅量级:不适用，未以先例校准任何幅度
形态:不适用
原文全文
展开原文 · 1,591 字
BREA, Calif.
,
Sept. 8, 2026
/
PRNewswire
/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference. The fireside chat will take place on Tuesday, September 15, 2026, from 9:40 – 10:10 AM ET.
A live audio webcast of the event, along with an archived replay, will be available in the Investors section of the Envista website at
https://investors.envistaco.com/
.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at
http://envistaco.com
.
FOR FURTHER INFORMATION
Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (424) 350-5259
ir@envistaco.com
SOURCE Envista Holdings Corporation
,
Sept. 8, 2026
/
PRNewswire
/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference. The fireside chat will take place on Tuesday, September 15, 2026, from 9:40 – 10:10 AM ET.
A live audio webcast of the event, along with an archived replay, will be available in the Investors section of the Envista website at
https://investors.envistaco.com/
.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at
http://envistaco.com
.
FOR FURTHER INFORMATION
Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (424) 350-5259
ir@envistaco.com
SOURCE Envista Holdings Corporation
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。